Literature DB >> 29694994

Predicting the Future: Delivery Room Planning of Congenital Heart Disease Diagnosed by Fetal Echocardiography.

Mary T Donofrio1.   

Abstract

Advances in prenatal imaging have improved the examination of the fetal cardiovascular system. Fetal echocardiography facilitates the prenatal diagnosis of congenital heart disease (CHD) and through sequential examination, allows assessment of fetal cardiac hemodynamics, predicting the evolution of anatomical and functional cardiovascular abnormalities in utero and during the transition to a postnatal circulation at delivery. This approach allows detailed diagnosis with prenatal counseling and enables planning to define perinatal management, selecting the fetuses at a risk of postnatal hemodynamic instability who are likely to require a specialized delivery plan. The prenatal diagnosis and management of critical neonatal CHD has been shown to play an important role in improving the outcome of newborns with these conditions, allowing timely stabilization of the circulation prior to cardiac intervention or surgery, thus reducing the risk of perioperative morbidity and mortality. Diagnostic protocols aimed at risk-stratifying severity and potential postnatal compromise in fetuses with CHD have been developed to identify those who may require special intervention at birth or within the first days of life. In addition, new methodologies are being studied to improve the accuracy of prediction of disease severity. Perinatal management of neonates with a prenatal diagnosis of CHD requires a close collaboration between obstetric, neonatal, and cardiology services. In this article, the management of fetuses with CHD will be discussed, along with summarizing the in utero and fetal echocardiographic findings used for risk stratification of newborns with CHD and reviewing the basic principles used for planning for neonatal resuscitation and initial transitional care of these complex newborns. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29694994     DOI: 10.1055/s-0038-1637764

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

1.  Distance from home to birth hospital, transfer, and mortality in neonates with hypoplastic left heart syndrome in California.

Authors:  Neha J Purkey; Chen Ma; Henry C Lee; Susan R Hintz; Gary M Shaw; Doff B McElhinney; Suzan L Carmichael
Journal:  Birth Defects Res       Date:  2022-04-29       Impact factor: 2.661

2.  Delivery Outcome of Fetuses with Congenital Heart Disease-Is It Influenced by Prenatal Diagnosis?

Authors:  Alina Weissmann-Brenner; Noam Domniz; Raanan Meyer; Tal Weissbach; Tal Elkan; Yishai Salem; Yossi Bart; Eran Kassif; Boaz Weisz
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

Review 3.  Understanding False Negative in Prenatal Testing.

Authors:  Mark I Evans; Ming Chen; David W Britt
Journal:  Diagnostics (Basel)       Date:  2021-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.